Annual Report 2021

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2021 88 The United Laboratories International Holdings Limited Annual Report 2021 5. REVENUE AND SEGMENT INFORMATION (Continued) Segment information (Continued) (b) Other segment information Amounts included in the measurement of segment profit or loss: For the year ended 31 December 2021 Intermediate Bulk Finished products medicine products Unallocated Consolidated RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 Amortisation of intangible assets 1,840 – 14,775 3 16,618 Depreciation of right-of-use assets 4,815 3,551 2,082 641 11,089 Depreciation of property, plant and equipment 451,505 88,348 47,152 6,145 593,150 Net loss on disposal of property, plant and equipment 8,744 10,134 503 – 19,381 Impairment losses recognised (reversed) 947 2,027 (362) 293,947 296,559